Retinoblastoma Protein-Interacting Zinc Finger 1 (RIZ1) Regulates the Proliferation of Monocytic Leukemia Cells via Activation of p53

REFERENCES

• Liu, L.; Shao, G.; Steele-Perkins, G.; Huang, S. The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem 1997, 272(5) 2984–2991.
   PubMed Web of Science ®Google Scholar
• He, L.; Yu, J.X.; Liu, L.; Buyse, I.M.; Wang, M.S.; Yang, Q.C.; Nakagawara, A.; Brodeur, G.M.; Shi, Y.E.; Huang, S. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 1998, 58(19), 4238–4244.
   PubMed Web of Science ®Google Scholar
• Jiang, G.; Liu, L.; Buyse, I.M.; Simon, D.; Huang, S. Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 1999, 83(4), 541–546.
   PubMed Web of Science ®Google Scholar
• Chadwick, R.B.; Jiang, G.L.; Bennington, G.A.; Yuan, B.; Johnson, C.K.; Stevens, M.W.; Niemann, T.H.; Peltomaki, P.; Huang, S.; de la Chapelle, A. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci USA 2000, 97(6), 2662–2667.
   PubMed Web of Science ®Google Scholar
• Sasaki, O.; Meguro, K.; Tohmiya, Y.; Funato, T.; Shibahara, S.; Sasaki, T. Altered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemia. Br J Haematol 2002, 119(4), 940–948.
   PubMed Web of Science ®Google Scholar
• Poetsch, M.; Dittberner, T.; Woenckhaus, C. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36. Oncogene 2002, 21(19), 3038–3042.
   PubMed Web of Science ®Google Scholar
• Du, Y.; Jenkins, N.A.; Copeland, N.G. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005, 106(12), 3932–3939.
   PubMed Web of Science ®Google Scholar
• Steele-Perkins, G.; Fang, W.; Yang, X.H.; Van Gele, M.; Carling, T.; Gu, J.; Buyse, I.M.; Fletcher, J.A.; Liu, J.; Bronson, R.; Chadwick, R.B.; de la Chapelle, A.; Zhang, X.; Speleman, F.; Huang, S. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase super family. Genes Dev 2001, 15(17), 2250–2262.
   PubMed Web of Science ®Google Scholar
• Du, Y.; Carling, T.; Fang, W.; Piao, Z.; Sheu, J.C.; Huang, S. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 2001, 61(22), 8094–8099.
   PubMed Web of Science ®Google Scholar
• Oshimo, Y.; Oue, N.; Mitani, Y.; Nakayama, H.; Kitadai, Y.; Yoshida, K.; Chayama, K.; Yasui, W. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer 2004, 110(2), 212–218.
   PubMed Web of Science ®Google Scholar
• Gazzerro, P.; Abbondanza, C.; D’Arcangelo, A.; Rossi, M.; Medici, N.; Moncharmont, B.; Puca, G.A. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Exp Cell Res 2006, 312(3), 340–349.
   PubMed Web of Science ®Google Scholar
• Pastural, E.; Takahashi, N.; Dong, W.F.; Bainbridge, M.; Hull, A.; Pearson, D.; Huang, S.; Lowsky, R.; DeCoteau, J.F.; Geyer, C.R. RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines. Oncogene 2007, 26(11), 1586–1594.
   PubMed Web of Science ®Google Scholar
• Meloni, F. Tumor necrosis factor alpha. Biological aspects. G Ital Chemioter 1989, 36(1–3), 29–37.
   PubMedGoogle Scholar
• Dinarello, C.A.; Cannon, J.G.; Wolff, S.M.; Bernheim, H.A.; Beutler, B.; Cerami, A.; Figari, I.S.; Palladino, M.A., Jr.; O’Connor, J.V. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986, 163(6), 1433–1450.
   PubMed Web of Science ®Google Scholar
• Beutler, B.; Cerami, A. Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation. Immunol Res 1986, 5(4), 281–293.
   PubMed Web of Science ®Google Scholar
• Old, L.J. Tumor necrosis factor (TNF). Science 1985, 230(4726), 630–632.
   PubMed Web of Science ®Google Scholar
• Sugarman, B.J.; Aggarwal, B.B.; Hass, P.E.; Figari, I.S.; Palladino, M.A., Jr.; Shepard, H.M. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 1985, 230(4728), 943–945.
   PubMed Web of Science ®Google Scholar
• Schweigerer, L.; Malerstein, B.; Gospodarowicz, D. Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. Biochem Biophys Res Commun 1987, 143(3), 997–1004.
   PubMed Web of Science ®Google Scholar
• Rusten, L.S.; Smeland, E.B.; Jacobsen, F.W.; Lien, E.; Lesslauer, W.; Loetscher, H.; Dubois, C.M.; Jacobsen, S.E. Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors. J Clin Invest 1994, 94(1), 165–172.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.; Harada, A.; Bluethmann, H.; Wang, J.B.; Nakao, S.; Mukaida, N.; Matsushima, K. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood 1995, 86(8), 2930–2937.
   PubMed Web of Science ®Google Scholar
• Caux, C.; Saeland, S.; Favre, C.; Duvert, V.; Mannoni, P.; Banchereau, J. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood 1990, 75(12), 2292–2298.
   PubMed Web of Science ®Google Scholar
• Widera, D.; Mikenberg, I.; Elvers, M.; Kaltschmidt, C.; Kaltschmidt, B. Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappa B signaling. BMC Neurosci 2006, 7(64), 1–18.
   PubMedGoogle Scholar
• Tsao, M.S.; Munzer, J.S.; Lee, D.; Phillips, N.C. The comparative effects of tumor necrosis factor on tumor cells growing anchorage dependently and independently. J Biol Response Mod 1989, 8(3), 297–304.
   PubMedGoogle Scholar
• Van Der Veen, A.H.; ten Hagen, T.L.; de Wilt, J.H.; van Ijken, M.G.; Eggermont, A.M. An overview on the use of TNF-alpha: our experience with regional administration and developments towards new opportunities for systemic application. Anticancer Res 2000, 20(5B) 3467–3474.
   PubMed Web of Science ®Google Scholar
• Ozes, O.N.; Mayo, L.D.; Gustin, J.A.; Pfeffer, S.R.; Pfeffer, L.M.; Donner, D.B. NF-kappa B activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401(6748) 82–85.
   PubMed Web of Science ®Google Scholar
• Wati, S.; Li, P.; Burrell, C.J.; Carr, J.M. Dengue Virus (DV) replication in monocyte-derived macrophages is not affected by tumor necrosis factor alpha (TNF-α), and dv infection induces altered responsiveness to TNF-α stimulation. J Virol 2007, 81(18), 10161–10171.
   PubMed Web of Science ®Google Scholar
• Hassan, F.; Islam, S.; Tumurkhuu, G.; Naiki, Y.; Koide, N.; Mori, I.; Yoshida, T.; Yokochi, T. Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide. BMC Cancer 2006, 6(281), 1–8.
   PubMedGoogle Scholar
• Chakravortty, D.; Kato, Y.; Sugiyama, T.; Koide, N.; Mu, M.M.; Yoshida, T.; Yokochi, T. The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling. J Immunol 2001, 166(3), 2011–2017.
   PubMed Web of Science ®Google Scholar
• Tsunoda, N.; Kokuryo, T.; Oda, K.; Senga, T.; Yokoyama, Y.; Nagino, M.; Nimura, Y.; Hamaguchi, M. Nek2 as a novel molecular target for the treatment of breast carcinoma. Cancer Sci 2009, 100(1), 111–116.
   PubMed Web of Science ®Google Scholar
• Sohmura, Y.; Nakata, K.; Yoshida, H.; Kashimoto, S.; Matsui, Y.; Furuichi, H. Recombinant human tumor necrosis factor-II. Antitumor effect on murine and human tumors transplanted in mice. Int J Immunopharmacol 1986, 8(3), 357–368.
   PubMed Web of Science ®Google Scholar
• Murase, T.; Hotta, T.; Saito, H.; Ohno, R. Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. Blood 1987, 69(2), 467–472.
   PubMed Web of Science ®Google Scholar
• Hehner, S.P.; Hofmann, T.G.; Dröge, W.; Schmitz, M.L. The anti-inflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 1999, 163(10), 5617–5623.
   PubMed Web of Science ®Google Scholar
• Vlahos, C.J.; Matter, W.F.; Hui, K.Y.; Brown, R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994, 269(7), 5241–5248.
   PubMed Web of Science ®Google Scholar
• Kim, K.C.; Geng, L.; Huang, S. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 2003, 63(22), 7619–7623.
   PubMed Web of Science ®Google Scholar
• Komarov, P.G.; Komarova, E.A.; Kondratov, R.V.; Christov-Tselkov, K.; Coon, J.S.; Chernov, M.V.; Gudkov, A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999, 285(5434), 1733–1737.
   PubMed Web of Science ®Google Scholar
• Pardee, A.B. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 1974, 71(4), 1286–1290.
   PubMed Web of Science ®Google Scholar
• Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100(1), 57–70.
   PubMed Web of Science ®Google Scholar
• Shin, S.I.; Freedman, V.H.; Risser, R.; Pollack, R. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA 1975, 72(11), 4435–4439.
   PubMed Web of Science ®Google Scholar
• Hasegawa, Y.; Matsubara, A.; Teishima, J.; Seki, M.; Mita, K.; Usui, T.; Oue, N.; Yasui, W. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Cancer Sci 2007, 98(1), 32–36.
   PubMed Web of Science ®Google Scholar
• Salyer, J.L.; Bohnsack, J.F.; Knape, W.A.; Shigeoka, A.O.; Ashwood, E.R.; Hill, H.R. Mechanisms of tumor necrosis factor-alpha alteration of PMN adhesion and migration. Am J Pathol 1990, 136(4), 831–841.
   PubMed Web of Science ®Google Scholar
• Pastor, D.M.; Irby, R.B.; Poritz, L.S. Tumor necrosis factor alpha induces p53 upregulated modulator of apoptosis expression in colorectal cancer cell lines. Dis Colon Rectum 2010, 53(3), 257–263.
   PubMed Web of Science ®Google Scholar
• Haranaka, K.; Satomi, N.; Sakurai, A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 1984, 34(2), 263–267.
   PubMed Web of Science ®Google Scholar
• Manda, T.; Shimomura, K.; Mukumoto, S.; Kobayashi, K.; Mizota, T.; Hirai, O.; Matsumoto, S.; Oku, T.; Nishigaki, F.; Mori, J.; Kikuchi, H. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity. Cancer Res 1987, 47(14), 3707–3711.
   PubMed Web of Science ®Google Scholar